A large number of oral antidiabetic drugs aimed to eliminate three major metabolic disorders leading to hyperglycemia-dysfunction of β-cells, peripheral insulin resistance, excessive hepatic glucose production [4, 5]. This evidence concerns the gene INS and metabolic disease.